News World AstraZeneca resumes trials of COVID vaccine halted by patient illness

AstraZeneca resumes trials of COVID vaccine halted by patient illness

AstraZeneca has resumed British clinical trials of its COVID-19 vaccine, one of the most advanced in development, after receiving the green light from safety watchdogs, the company said on Saturday.

The late-stage trials of the experimental vaccine, developed with researchers from the University of Oxford, were suspended this week after an illness in a study subject in Britain, casting doubts on an early rollout.

“On 6 September, the standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data by independent committees, and international regulators,” AstraZeneca said.

It added that safety reviewers had recommended to Britain’s Medicines Health Regulatory Authority (MHRA) that it was safe to resume the UK trials.

The patient involved in the study had been reportedly suffering from neurological symptoms associated with a rare spinal inflammatory disorder called transverse myelitis.

AstraZeneca, based in Cambridge, said it could not disclose further medical information.

Governments around the world are desperate for a vaccine to help end the pandemic, which has caused more than 900,000 deaths and global economic turmoil. The World Health Organisation (WHO) had flagged AstraZeneca’s as the most promising.

The pause of the trials came after reports that the United States was aiming for fast-track authorisation or approval of a vaccine before November’s presidential election.

Leading U.S. and European vaccine developers have pledged to uphold scientific safety and efficacy standards for their experimental vaccines and not bow to political pressures to rush the process.

AstraZeneca has already agreed to supply close to three billion doses to governments across the globe – more than any other vaccine project.

The WHO’s chief scientist said the pause in the trial should serve as a “wake-up” call that there would be ups and downs in the development of a vaccine.

(Reuters)

Top Stories

Nine new coronavirus cases detected out of 2,893 tests

The Ministry of Health has announced that 9 new cases of the SARS-CoV-II virus were detected in Cyprus over the past 24 hours out...

People must observe health protocols, Minister of Health stresses

Minister of Health, Constantinos Ioannou, said on Thursday that the goal is not to impose strict measures but rather to make people understand that...

Staff object to use of Famagusta Hospital as Reference Hospital

Doctors and nurses of the Famagusta General Hospital are up in arms about the continued use of it as the island's Reference Hospital for...

Papadouris sues Auditor General

Former Commissioner for Mountain Communities Giannakis Papadouris filed a lawsuit against Cyprus' Auditor General Odysseas Michailides, through the Christos Pourgourides & Sia law firm. As...

Larnaca sample testing of 3,000 people: Points and times

The Ministry of Health and the Municipality of Larnaca inform the public that as part of the effort to stop the spread of the...

Taste

Sheftalies

Sheftalies, a very tasty dish from the charcoal grill, are minced meat shaped into small sausages and wrapped in “panna” (suet). Panna is a...

Spicy grilled soutzoukakia

Place all ingredients for soutzoukakia in a bowl and mix well, preferably using a food processor, until well combined. Using the mixture, form cigar-shaped...

Souvlakia

Pork souvlaki: Put the meat and all the other ingredients in a bowl (not metal) and mix well. Cover the bowl and keep in...

Pastelli (Carob Toffee)

The nutritional sweet of Pastelli is made with the syrup of carob pods, produced by boiling their pulp until it forms a thick, sticky...